NasdaqCM · Technology · Financials
Aehr Test Systems (AEHR) financial statements and cash flow.
Revenue, profitability, balance-sheet strength, and cash generation for AEHR. Market data source · as of 2026-02-27 · Market data source · as of 2026-05-29.
Section freshness
Price Sep 3, 4:00 PM EDT · Statements Feb 26, 7:00 PM EST
Financial read
AEHR latest financial snapshot.
Start with the latest reported values below. Deeper quarterly and annual statement tables follow when supplied.
Revenue
$10.31M
-23.3% YoY
Net income
-$3.20M
+0.8% QoQ
Gross margin
32.66%
Gross profit $3.37M
Net margin
-31.06%
Operating margin -41.01%
Balance sheet coverage
AEHR balance sheet summary
Assets, liabilities, liquidity, debt, and equity sit beside income and cash-flow tables so the statement history reads as one model-ready dataset.
20 quarterly · 4 annual rows · Market data source · as of 2026-05-29
Latest period
Q2 FY2026
20 quarterly · 4 annual rows
Assets / liabilities
$246.69M
Liabilities $27.18M
Cash / debt
$116.36M
Net cash —
Equity / working capital
$219.51M
Working capital $166.59M
Financial statements
AEHR statement coverage.
Income statement, balance sheet, and cash-flow figures for AEHR, with quarterly and annual history in the tables below.
Data last updated
Feb 26, 2026
Income periods
22
Balance-sheet periods
24
Cash-flow periods
22
Quarterly and annual AEHR statements, sourced from Market data source · as of 2026-02-27 · Market data source · as of 2026-05-29.
Financial statement period
AEHR statement history
Market data source · as of 2026-02-27 · Market data source · as of 2026-05-29 · Data last updated: Feb 26, 2026
Income statement
Quarterly and annual rows for revenue, operating leverage, earnings quality, and margin direction.
| Period | Revenue | Gross profit | Operating income | Interest income | Continuing ops | Net income | Comprehensive income | Net margin | Revenue QoQ | Net income QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | $10.31M | $3.37M | -$4.23M | -$3.20M | -31.06% | +4.3% | +0.8% | |||
| Q4 FY2025 | $9.88M | $2.54M | -$4.65M | -$3.23M | -32.68% | -9.9% | -55.0% | |||
| Q3 FY2025 | $10.97M | $3.72M | -$4.07M | -$2.08M | -19.00% | -40.1% | -224.1% | |||
| Q1 FY2025 | $18.31M | $7.18M | -$1.12M | -$643,000 | -3.51% | +36.1% | +37.5% | |||
| Q4 FY2024 | $13.45M | $5.40M | -$1.51M | -$1.03M | -7.64% | +2.5% | -255.8% | |||
| Q3 FY2024 | $13.12M | $7.08M | $159,000 | $660,000 | 5.03% | +73.5% | +144.9% | |||
| Q1 FY2024 | $7.56M | $3.16M | -$2.05M | -$1.47M | -19.45% | -64.7% | -124.2% | |||
| Q4 FY2023 | $21.43M | $10.96M | $5.47M | $6.09M | 28.41% | +3.9% | +30.3% |
Balance sheet
Balance-sheet history for assets, liabilities, liquidity, debt, equity, and shares outstanding.
| Period | Cash | Current assets | Current liabilities | Total assets | Total liabilities | Total debt | Capital leases | Total equity | Shares | Debt QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | $116.36M | $184.45M | $17.86M | $246.69M | $27.18M | $219.51M | ||||
| Q1 FY2026 | $36.91M | $95.90M | $8.74M | $157.05M | $18.25M | $138.79M | ||||
| Q4 FY2025 | $30.84M | $88.19M | $8.30M | $148.73M | $17.96M | $130.78M | ||||
| Q3 FY2025 | $22.71M | $84.05M | $11.91M | $144.09M | $21.70M | $122.39M | ||||
| Q2 FY2025 | $24.53M | $88.78M | $15.64M | $148.51M | $25.64M | $122.87M | ||||
| Q1 FY2025 | $29.41M | $91.70M | $16.06M | $145.61M | $21.40M | $124.21M | ||||
| Q4 FY2024 | $32.22M | $88.52M | $11.72M | $142.28M | $19.10M | $123.18M | ||||
| Q3 FY2024 | $37.83M | $92.92M | $15.42M | $145.86M | $23.38M | $122.48M |
Cash flow
Operating cash generation, capital expenditure, free cash flow, buybacks, dividends, and cash movement.
| Period | Operating cash flow | CapEx | Free cash flow | Net income | Stock comp | Debt issuance | Dividends paid | Buybacks | Change in cash | FCF QoQ |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | -$3.20M | |||||||||
| Q4 FY2025 | -$3.23M | |||||||||
| Q3 FY2025 | -$2.08M | |||||||||
| Q1 FY2025 | -$643,000 | |||||||||
| Q4 FY2024 | -$1.03M | |||||||||
| Q3 FY2024 | $660,000 | |||||||||
| Q1 FY2024 | -$1.47M | |||||||||
| Q4 FY2023 | $6.09M |
Valuation and returns
- Enterprise value
- $2.84B
- Market data source
- Return on equity
- -4.16%
- Market data source
- Return on assets
- -4.47%
- Market data source
Ratio values use provider-attributed fields when available and otherwise fall back to TECHi statement math from the visible rows on this page.
Annual revenue and income multiples
Annual sales and income multiple reads use the latest annual statement when available, then fall back to trailing-twelve-month statement math from the visible quarterly rows.
- Annual revenue base
- $49.47M
- Annual statement 2022-11-30
- Annual income base
- $12.35M
- Annual statement 2022-11-30
- Market cap / annual revenue
- 50.29
- Live market value divided by annual revenue
- Market cap / annual income
- 201.44
- Live market value divided by annual net income
Annual sales and income multiple
Market capitalization bridge
TTM valuation multiples
- TTM revenue
- $49.47M
- Trailing twelve months
- TTM EBIT
- -$14.06M
- TTM operating income
- Market cap / TTM revenue
- 50.29
- Live market value divided by trailing twelve months revenue
- EV / TTM revenue
- 57.50
- Enterprise value divided by trailing twelve months revenue
Live market value is matched against trailing-twelve-month statement bases first so the multiple moves with the tape instead of anchoring to stale fiscal-year rows.
Revenue, net income, and free cash flow
Quarterly statement rows, shown on one common dollar scale so margin compression and cash conversion stand out quickly.
Efficiency
Growth vs cost pressure
Quarterly margin heatmap
Latest quarter expense mix
Profit bridge
Other income statement lines
Balance sheet · Q2 FY2026
- Cash & equivalents
- $116.36M
- Total equity
- $219.51M
Balance sheet detail
- Current assets
- $184.45M
- Current liabilities
- $17.86M
- Inventory
- $41.35M
- Property, plant & equipment
- $8.94M
Debt and liquidity
Cash + short-term investments + receivables / current liabilities
Cash generation
Frequently asked
Common questions.
What financial data is available for AEHR?
The AEHR Financials page renders only the current income-statement, balance-sheet, cash-flow, or fund rows supplied for Aehr Test Systems. Missing modules and empty line items are omitted.
How current are AEHR's financial statements?
Each visible statement row keeps its reported period and provider attribution. The route redirects to the main quote when no usable financial or fund data remains.
What is Aehr Test Systems's reported net margin?
Aehr Test Systems's fresh reported margin field is -14.20%. The Financials page shows the supporting period data currently available for AEHR.